BD to Acquire CareFusion for USD 12.2 Billion

BD (Franklin Lakes, NJ, USA), formerly Becton Dickinson & Co, and CareFusion (San Diego, CA, USA) have announced a definitive agreement under which BD will acquire CareFusion, creating a global leader in medication management and patient safety solutions.

The combination of the two companies' complementary product portfolios will offer integrated medication management solutions and smart devices, from drug preparation in the pharmacy, to dispensing on the hospital floor, administration to the patient, and subsequent monitoring. The combination is designed to address unmet needs in hospitals, hospital pharmacies, and alternate sites of care by increasing efficiencies, reducing medication administration errors, and improving patient and healthcare worker safety.

The acquisition is designed to accelerate BD's strategy to improve quality of care and reduce healthcare costs, as well as enhances emerging market growth opportunities. A detailed execution plan will be implemented to ensure a seamless integration, following which CareFusion will operate as part of BD's medical segment. A designated integration team, comprised of senior members of both organizations, will identify potential areas to consolidate cost synergies.

“BD's acquisition of CareFusion allows us to align our highly complementary technologies and products to address unmet needs in the growing 20 billion global medication management industry, which leverages BD's world-wide infrastructure,” said Vincent Forlenza, chairman, CEO, and president of BD. “It accelerates BD's transition from a product-focused company to a customer-centric provider of innovative healthcare solutions with leading scale across the medication management value chain and expanded solutions for patient safety.”

“As part of BD, we see new growth opportunities for our products in global markets, new value we can create for our customers and new opportunities for our employees as part of what will become one of the largest, global leaders in med-tech,” said Kieran Gallahue, chairman and CEO of CareFusion. “The transaction delivers attractive value for CareFusion shareholders, and represents a powerful endorsement of our strong positions in medication management, informatics across our device platforms and leading products to help improve the effectiveness of acute-care procedures.”

BD is a medical technology company that manufactures and sells a broad range of medical supplies, devices, laboratory equipment, and diagnostic products to healthcare institutions, life science researchers, clinical laboratories, industry, and the general public.

CareFusion is a global medical technology corporation that specializes in two areas—reducing medication errors and prevention of health care-associated infections.

Related Links:
BD
CareFusion